For some of you, going through an acquisition may not be a new experience. Entering into the definitive
agreement is the first step in this process. It will take a few months from now to finalize the acquisition, pending regulatory approval and other customary closing conditions. In the meantime, we continue to operate as separate
companies. There are a lot of details that have yet to be worked out, so teams from both companies will soon begin working together on integration plans to ensure the combined company is best positioned for success.
As all of you will know, I care deeply about this company, our patients, and our employees. Hence, I plan to stay on board for the remainder of the year,
leading the GW part of the business, to help ensure a smooth transition. Similar commitments are being made from other members of the Executive Leadership Team.
You likely have a lot of questions about what todays news means, and although we may not have all the answers straight away, we are committed to
frequent communication and sharing information as it becomes available. We have created several resources to help you learn more about this transaction and what it means for you, including a detailed Q&A document, which will be made
available later today and updated as new information becomes available.
I will also be leading a Global All Employee Meeting today at 8:00 am PT / 4:00 pm
GMT. Please do join if possible.
Following the global meeting today, on Friday at 7:00 am PT / 3:00 pm GMT, you will also have an opportunity to hear
from Bruce Cozadd, Chairman and CEO of Jazz, who will join me for another Global All Employee Meeting. Meeting invites will be issued shortly.
I
believe todays announcement validates just how far weve come on our journey together and represents a tremendous opportunity for our patients and employees moving forward. We can take pride knowing that together we
have created a valuable organization that is positively impacting many lives. As we prepare for the next chapter in our companys evolution, I believe that the combination of these two purpose-led and
values-based companies will continue to make a tremendous difference in the lives of countless families around the world.
I look forward to speaking with
you later today.
Regards
Justin
**Please carefully review important information in the attached document**
Justin Gover I Chief Executive Officer
5750 Fleet Street, Suite 200, Carlsbad, CA 92008 I Tel: 760 795 2200
UK Office Tel: +44 207 291 0555
www.gwpharm.com